Biotechnology

Techseriesinsight > Blog > News > Biotechnology

December 23, 2025
Business Wire
Biotechnology, News

Agenus Reports Deep, Durable Responses with Botensilimab + Balstilimab in Highly Refractory Ovarian Cancer, Published in JITC

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the publication of clinical results from the ovarian cancer cohort of its Phase 1b C-800-01 trial evaluating botensilimab plus balstilimab...

December 15, 2025
Business Wire
Biotechnology, News

NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation

A leading provider of oncology diagnostic solutions that enable precision medicine, today announced that Natera voluntarily dismissed its appeal (and NeoGenomics thus dismissed its cross-appeal) of the North Carolina...

December 12, 2025
Business Wire
Biotechnology, News

Tharimmune, Inc. Appoints Jacob Asbury as Chief Financial Officer to Advance Canton Coin Treasury Strategy

The first publicly traded company to leverage Canton Coin (“CC”) to support the Canton Network’s ability to digitize traditional financial markets, today announced the appointment of seasoned financial executive...

December 11, 2025
Business Wire
Biotechnology, News

Zegenex Secures Social-Impact Investment from Richard King Mellon Foundation to Accelerate Breakthrough Wound Healing Solution

A biotechnology company specializing in innovative healing solutions, announced it has received a $215,000 social-mission investment from the Richard King Mellon Foundation. The funding will support formulation optimization and...

December 9, 2025
Business Wire
Biotechnology, News

ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive

A world-leading clinical research organisation, today released findings from two biotech sector surveys. The first survey focused on global biotech trends and is an update of our 2023 survey,...

December 8, 2025
Business Wire
Biotechnology, News

Kallyope Announces Positive Results from Phase 2b Study of Elismetrep for the Acute Treatment of Migraine

Kallyope, a late-stage biotechnology company leveraging unique insights into neural signaling pathways to develop innovative therapies for migraine and metabolism, today announced positive results from a Phase 2b study...

December 4, 2025
Business Wire
Biotechnology, News

Sunbird Bio Presents New Clinical Data Supporting the Accuracy of its Blood-Based Alpha-Synuclein Assay for Parkinson’s Disease Detection

Sunbird Bio, a biotechnology company developing proprietary blood-based technologies to improve diagnosis and treatment of neurological disorders, announced new data demonstrating that the company’s blood-based sunbird αSyn™ assay accurately...

December 3, 2025
Business Wire
Biotechnology, News

Junevity Expands Seed Funding to $20 Million for Cell Reprogramming with siRNA

A biotechnology company on a mission to extend lifespan and healthspan with cell reprogramming, raised $10 million in new funding, bringing its Seed financing to a total of $20 million....

December 2, 2025
Business Wire
Biotechnology, News

Primecore Announces 100 Jobs Over the Next Three Years

Primecore, a program management consultancy serving the science and technology sectors, has announced a new leadership team and a significant investment that will see the company grow by over...

December 1, 2025
Business Wire
Biotechnology, News

McKesson’s Advancing Community Oncology Report Charts a New Era of Innovation for Biopharma and Community Care

McKesson Corporation today announced the publication of its first-ever Advancing Community Oncology Report, a comprehensive look at the trends influencing community-based oncology practices across the United States, combined with expert perspectives...